Vertex Pharmaceuticals

HIRING · 3 OPEN AI

About

Job Description
Research Scientist, Computational Drug Design
General Summary
We are seeking a highly motivated and experienced computational chemist to join our Computational Drug Design group in Boston. This individual will be responsible for contributing to both hit/lead identification and optimization programs using methods encompassing all computational aspects of drug discovery. The right candidate's responsibilities include close interaction with interdisciplinary projects teams to ide...

Vertex Pharmaceuticals

About

Updates & Highlights

Vertex Pharmaceuticals Earnings on Deck: What To Expect From VRTX

Vertex Pharmaceuticals (VRTX) Q2 Earnings Report Preview: What To Look For

Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript

Recent Openings

Research Scientist, Human Cell Models (Contract)

Pharmacology Research Scientist

Computational Chemistry Senior Research Scientist

All Jobs

Research Scientist, Human Cell Models (Contract)

Pharmacology Research Scientist

Computational Chemistry Senior Research Scientist

Culture & Mission

Benefits & Perks

Equity/Stock Options

Health Insurance

Remote Work

Learning Budget

Generous PTO

Competitive Salary

Tech Stack

Core Values

Innovation

Collaboration

Excellence

Impact

Office Locations

Team

Are you on the team at Vertex Pharmaceuticals?

News & Press

Vertex Pharmaceuticals Earnings on Deck: What To Expect From VRTX

Vertex Pharmaceuticals (VRTX) Q2 Earnings Report Preview: What To Look For

Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript

Vertex Pharmaceuticals Stock (VRTX) Opinions on Upcoming Earnings

Vertex–AbCellera T‑Cell Engager Alliance Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)

Vertex–AbCellera T‑Cell Engager Alliance Might Change The Case For Investing In Vertex Pharmaceuticals (VRTX)

Is Vertex Pharmaceuticals (VRTX) Cheap On Its AbCellera Collaboration News?

Vertex Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors

Vertex Pharmaceuticals (VRTX) Expands Its Pipeline Reach, Is The Stock Fully Valued?

Vertex Pharmaceuticals (VRTX) Stock Looks Like A Bargain At This Price

Vertex Pharmaceuticals (NASDAQ:VRTX): Strong Growth and Textbooks Technical Setup for Breakout

Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider

Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains

Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know

Vertex Pharmaceuticals (VRTX) Earnings Expected to Grow: Should You Buy?

Vertex Pharmaceuticals (VRTX) Wins FDA Nod To Treat Children As Young As 2

Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching

Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching

Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains

Lobbying Update: $1,200,000 of VERTEX PHARMACEUTICALS INCORPORATED lobbying was just disclosed